PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-06-17

Date Title Company
17-Jun-2020 Graphene Market Booming at high CAGR of 42.16 % by 2026 with Top Key Players: Haydale Graphene Indus, Applied Graphene Materials plc, Graphene 3D Lab Inc, Vorbeck Materials Wired Release
17-Jun-2020 Increasing number of hydroxychloroquine clinical trials for COVID-19 treatment will be withdrawn or terminated, says GlobalData GlobalData
17-Jun-2020 4basebio AG: 4basebio reports on results of Annual General Meeting 2020 4basebio AG
17-Jun-2020 Payment Processing Solutions Market Is Expected To Reach USD 7,253.57 Million By 2027 Top Players are Mastercard, Network International, The Mint Corporation, FIS, GPS, Wirecard, PayPal, PayU Wired Release
17-Jun-2020 Methanol Market Is Expected To Reach An Projected Value Of USD 130.68 Billion By 2026 | SABIC, Celanese Corporation, Eastman Chemical Company, BASF SE, Atlantic Methanol, Methanex Corporation Wired Release
17-Jun-2020 Legal Operations Software Market Is Expected To Witness Market Growth At A Rate Of 14.1% In The During 2020 To 2027 | LexisNexis, Wolters Kluwer ELM Solutions, Inc., Thomson Reuters, Mitratech Holdings, Inc Wired Release
17-Jun-2020 Green Fluorescent Protein Market: By Types, Application, Geography, Competitors 2026 | Thermo Fisher Scientific, Biocompare, Merck KGaA, Novus Biologicals Wired Release
17-Jun-2020 Zika Virus Infection Drug Market: Latest Innovations, Drivers And Industry Key Events 2026 | Emergent BioSolutions Inc, Valneva SE, Moderna Wired Release
17-Jun-2020 Healthcare 3D Printing Market: Anticipated To Predict A Promising Growth By 2026 | 3D Systems, Inc., GE, EnvisionTEC, EOS, Integer Holdings Corporation Wired Release
17-Jun-2020 curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG curasan AG
17-Jun-2020 Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice Novo Nordisk
17-Jun-2020 Faron receives €2.1 million funding from Business Finland for Traumakine manufacturing Faron Pharmaceuticals Ltd
17-Jun-2020 Kyowa Kirin makes POTELIGEO® (mogamulizumab) available in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome, Two Rare Forms of Non-Hodgkin’s Lymphoma with High Unmet Medical Need Kyowa Kirin
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare
17-Jun-2020 Wipro launches Digital Inspection Solution powered by IBM® TRIRIGA® Wipro Limited
17-Jun-2020 Rybelsus® was more effective in achieving clinically relevant blood sugar and weight reductions in people with type 2 diabetes vs all active comparators Novo Nordisk
17-Jun-2020 UPS HEALTHCARE CONTINUES GLOBAL FACILITY EXPANSION TO MEET GROWING DEMANDS IN KEY MARKETS UPS Healthcare
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare
17-Jun-2020 Faron provides update on pipeline progress ahead of R&D Day Faron Pharmaceuticals Oy
17-Jun-2020 New Data from Phase 3 Studies Support Maintained Transfusion Independence* for Patients Across Genotypes Treated with betibeglogene autotemcel (LentiGlobin for β-thalassaemia) Gene Therapy bluebird bio